Search
for
Sort by
Research 91–120 of 1000+
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Trichoscopic findings of androgenetic alopecia and their association with disease severity
- Association of male pattern baldness with angiographic coronary artery disease severity and collateral development
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Evaluation of clinical and trichoscopic features of androgenetic alopecia and its relation with disease severity
- Low level of high-density lipoprotein cholesterol is solely associated with greater severity of male androgenetic alopecia: A cross-sectional study of Thai population
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Faculty Opinions recommendation of A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification.
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
- Classifications of patterned hair loss: a review
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29
- Classification of male-pattern hair loss
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- SLE classification criteria item relationships: implications on SLE as a disease entity
- A cross sectional study evaluating the relationship of acne to androgenetic alopecia subtype and severity
- Two‐dimensional planimetry for alopecia areata severity evaluation compared with severity of alopecia tool: A pilot study
- Contents Vol. 4, 2018